Meeting
2014 ASCO Annual Meeting
Features of adult clinical trial participants with glioblastoma (GB) at The University of Texas MD Anderson Cancer Center (MDACC).
Authors
Mark Daniel Anderson
University of Mississippi Medical Center, Jackson, MS
Mark Daniel Anderson , Diane Liu , Jimin Wu , Marta Penas-Prado , John Frederick De Groot
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 2038)
DOI
10.1200/jco.2014.32.15_suppl.2038
Abstract #
2038
Poster Bd #
3
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Surgically targeted radiation therapy (STaRT) for recurrent glioblastoma: Initial outcomes from a prospective multicenter registry.
First Author: Ahmad Ozair
Poster
2024 ASCO Breakthrough
An investigator-initiated trial to evaluate safety and tolerability of YSCH-01 in patients with recurrent glioblastoma.
First Author: Hafiz Khuram Raza
Poster
2023 ASCO Annual Meeting
Ombipepimut dosing emulsion (ODE) + bevacizumab (bev) vs bev alone in patients (pts) with recurrent or progressive glioblastoma (rGBM).
First Author: Samuel Aaron Goldlust
Poster
2023 ASCO Annual Meeting
The value of progression-free survival at three years as a primary endpoint for studies on radiotherapy in patients with locally advanced cervical cancer: Individual patient data from Chinese National Cancer Center and validation from 27 global randomized trials.
First Author: Xi Yang